"10.1371_journal.pone.0116237","plos one","2015-02-02T00:00:00Z","Minrong Ai; Yajun Cui; Man-Sun Sy; David M Lee; Ling Xiu Zhang; Katherine M Larson; Kyle C Kurek; Gregory D Jay; Matthew L Warman","Howard Hughes Medical Institute and Department of Genetics, Case Western Reserve University, School of Medicine, Cleveland, OH, United States of America; Department of Pathology, Case Western Reserve University, School of Medicine, Cleveland, OH, United States of America; Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Boston, MA, United States of America; Department of Emergency Medicine, Rhode Island Hospital, Providence, RI, United States of America; School of Engineering, Brown University, Providence, RI, United States of America; Department of Pathology, Boston Children’s Hospital, Boston, MA, United States of America; Howard Hughes Medical Institute and Orthopaedics Research Laboratories, Boston Children’s Hospital, and Departments of Genetics and Orthopaedic Surgery, Harvard Medical School, Boston, MA, United States of America","Conceived and designed the experiments: MA GDJ M-SS DML GDJ MLW. Performed the experiments: MA YC DML LXZ KML KCK GDJ MLW. Analyzed the data: MA YC M-SS DML LXZ KML KCK GDJ MLW. Contributed reagents/materials/analysis tools: GDJ DML KCK. Wrote the paper: MA YC M-SS DML KCK GDJ MLW.","Case Western Reserve University has licensed mAb-5c11 and mAb-9g3 (for MA, YC, MS, GDJ, and MLW) to EMD Millipore (Billerica, MA). GDJ has authored and was granted a United States patent “Tribonectin polypeptides and uses thereof,” no. 6743774 for the therapeutic use of lubricin in joints. Dr. Jay receives support from a Phase II STTR for clinical translation efforts related to his patent. The present paper neither materially nor financially affects Dr. Jay’s patent relating to rhPRG4. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2015","02","Minrong Ai","MA",9,TRUE,5,8,9,7,TRUE,TRUE,FALSE,0,NA,FALSE
